Re: First-in-Human Study of the Radioligand 68Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma: Navigating Metastatic Urothelial Cancer with Nectin-4 PET/CT

Klümper N, Eckstein M, Hölzel M, Herrmann K, Hadaschik B, Grünwald V (2023)

Publication Type: Journal article

Publication year: 2023

Journal

European Urology Elsevier

DOI: 10.1016/j.eururo.2023.05.029

Involved external institutions

Universitätsklinikum Bonn DE Germany (DE) BRIDGE Consortium e.V. (Bladder Cancer Research Initiative for Drug Targets Germany) DE Germany (DE) Universitätsklinikum Essen DE Germany (DE) Deutsches Krebsforschungszentrum (DKFZ) DE Germany (DE)

How to cite

APA:

Klümper, N., Eckstein, M., Hölzel, M., Herrmann, K., Hadaschik, B., & Grünwald, V. (2023). Re: First-in-Human Study of the Radioligand 68Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma: Navigating Metastatic Urothelial Cancer with Nectin-4 PET/CT. European Urology. https://doi.org/10.1016/j.eururo.2023.05.029

MLA:

Klümper, Niklas, et al. "Re: First-in-Human Study of the Radioligand 68Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma: Navigating Metastatic Urothelial Cancer with Nectin-4 PET/CT." European Urology (2023).

BibTeX: Download